184 related articles for article (PubMed ID: 9548596)
1. 7-Dehydrocholesterol down-regulates cholesterol biosynthesis in cultured Smith-Lemli-Opitz syndrome skin fibroblasts.
Honda M; Tint GS; Honda A; Nguyen LB; Chen TS; Shefer S
J Lipid Res; 1998 Mar; 39(3):647-57. PubMed ID: 9548596
[TBL] [Abstract][Full Text] [Related]
2. 7-Dehydrocholesterol-dependent proteolysis of HMG-CoA reductase suppresses sterol biosynthesis in a mouse model of Smith-Lemli-Opitz/RSH syndrome.
Fitzky BU; Moebius FF; Asaoka H; Waage-Baudet H; Xu L; Xu G; Maeda N; Kluckman K; Hiller S; Yu H; Batta AK; Shefer S; Chen T; Salen G; Sulik K; Simoni RD; Ness GC; Glossmann H; Patel SB; Tint GS
J Clin Invest; 2001 Sep; 108(6):905-15. PubMed ID: 11560960
[TBL] [Abstract][Full Text] [Related]
3. Regulation of cholesterol biosynthetic pathway in patients with the Smith-Lemli-Opitz syndrome.
Honda M; Tint GS; Honda A; Salen G; Shefer S; Batta AK; Matsuzaki Y; Tanaka N
J Inherit Metab Dis; 2000 Jul; 23(5):464-74. PubMed ID: 10947201
[TBL] [Abstract][Full Text] [Related]
4. Sterol concentrations in cultured Smith-Lemli-Opitz syndrome skin fibroblasts: diagnosis of a biochemically atypical case of the syndrome.
Honda A; Tint GS; Salen G; Kelley RI; Honda M; Batta AK; Chen TS; Shefer S
Am J Med Genet; 1997 Jan; 68(3):282-7. PubMed ID: 9024560
[TBL] [Abstract][Full Text] [Related]
5. Rapid identification of Smith-Lemli-Opitz syndrome homozygotes and heterozygotes (carriers) by measurement of deficient 7-dehydrocholesterol-delta 7-reductase activity in fibroblasts.
Shefer S; Salen G; Honda A; Batta A; Hauser S; Tint GS; Honda M; Chen T; Holick MF; Nguyen LB
Metabolism; 1997 Jul; 46(7):844-50. PubMed ID: 9225842
[TBL] [Abstract][Full Text] [Related]
6. Screening for abnormal cholesterol biosynthesis in the Smith-Lemli-Opitz syndrome: rapid determination of plasma 7-dehydrocholesterol by ultraviolet spectrometry.
Honda A; Batta AK; Salen G; Tint GS; Chen TS; Shefer S
Am J Med Genet; 1997 Jan; 68(3):288-93. PubMed ID: 9024561
[TBL] [Abstract][Full Text] [Related]
7. Bile acid synthesis in the Smith-Lemli-Opitz syndrome: effects of dehydrocholesterols on cholesterol 7alpha-hydroxylase and 27-hydroxylase activities in rat liver.
Honda A; Salen G; Shefer S; Batta AK; Honda M; Xu G; Tint GS; Matsuzaki Y; Shoda J; Tanaka N
J Lipid Res; 1999 Aug; 40(8):1520-8. PubMed ID: 10428990
[TBL] [Abstract][Full Text] [Related]
8. Treatment of the cholesterol biosynthetic defect in Smith-Lemli-Opitz syndrome reproduced in rats by BM 15.766.
Xu G; Salen G; Shefer S; Ness GC; Chen TS; Zhao Z; Salen L; Tint GS
Gastroenterology; 1995 Oct; 109(4):1301-7. PubMed ID: 7557099
[TBL] [Abstract][Full Text] [Related]
9. Cholesterol storage defect in RSH/Smith-Lemli-Opitz syndrome fibroblasts.
Wassif CA; Vied D; Tsokos M; Connor WE; Steiner RD; Porter FD
Mol Genet Metab; 2002 Apr; 75(4):325-34. PubMed ID: 12051964
[TBL] [Abstract][Full Text] [Related]
10. No evidence for mevalonate shunting in moderately affected children with Smith-Lemli-Opitz syndrome.
Roullet JB; Merkens LS; Pappu AS; Jacobs MD; Winter R; Connor WE; Steiner RD
J Inherit Metab Dis; 2012 Sep; 35(5):859-69. PubMed ID: 22391996
[TBL] [Abstract][Full Text] [Related]
11. Feedback inhibition of the cholesterol biosynthetic pathway in patients with Smith-Lemli-Opitz syndrome as demonstrated by urinary mevalonate excretion.
Pappu AS; Steiner RD; Connor SL; Flavell DP; Lin DS; Hatcher L; Illingworth DR; Connor WE
J Lipid Res; 2002 Oct; 43(10):1661-9. PubMed ID: 12364550
[TBL] [Abstract][Full Text] [Related]
12. Residual cholesterol synthesis and simvastatin induction of cholesterol synthesis in Smith-Lemli-Opitz syndrome fibroblasts.
Wassif CA; Krakowiak PA; Wright BS; Gewandter JS; Sterner AL; Javitt N; Yergey AL; Porter FD
Mol Genet Metab; 2005 Jun; 85(2):96-107. PubMed ID: 15896653
[TBL] [Abstract][Full Text] [Related]
13. Peroxisomal cholesterol biosynthesis and Smith-Lemli-Opitz syndrome.
Weinhofer I; Kunze M; Stangl H; Porter FD; Berger J
Biochem Biophys Res Commun; 2006 Jun; 345(1):205-9. PubMed ID: 16678134
[TBL] [Abstract][Full Text] [Related]
14. Defective conversion of 7-dehydrocholesterol to cholesterol in cultured skin fibroblasts from Smith-Lemli-Opitz syndrome homozygotes.
Honda A; Tint GS; Salen G; Batta AK; Chen TS; Shefer S
J Lipid Res; 1995 Jul; 36(7):1595-601. PubMed ID: 7595082
[TBL] [Abstract][Full Text] [Related]
15. [Inborn error of cholesterol biosynthesis: Smith-Lemli-Opitz syndrome].
Koczok K; V Oláh A; P Szabó G; Oláh É; Török O; Balogh I
Orv Hetil; 2015 Oct; 156(42):1695-702. PubMed ID: 26551309
[TBL] [Abstract][Full Text] [Related]
16. Cholesterol supplementation with egg yolk increases plasma cholesterol and decreases plasma 7-dehydrocholesterol in Smith-Lemli-Opitz syndrome.
Linck LM; Lin DS; Flavell D; Connor WE; Steiner RD
Am J Med Genet; 2000 Aug; 93(5):360-5. PubMed ID: 10951458
[TBL] [Abstract][Full Text] [Related]
17. Abnormal cholesterol biosynthesis in sitosterolaemia and the Smith-Lemli-Opitz syndrome.
Salen G; Shefer S; Batta AK; Tint GS; Xu G; Honda A
J Inherit Metab Dis; 1996; 19(4):391-400. PubMed ID: 8884563
[TBL] [Abstract][Full Text] [Related]
18. Sterols and oxysterols in plasma from Smith-Lemli-Opitz syndrome patients.
Griffiths WJ; Abdel-Khalik J; Crick PJ; Ogundare M; Shackleton CH; Tuschl K; Kwok MK; Bigger BW; Morris AA; Honda A; Xu L; Porter NA; Björkhem I; Clayton PT; Wang Y
J Steroid Biochem Mol Biol; 2017 May; 169():77-87. PubMed ID: 26976653
[TBL] [Abstract][Full Text] [Related]
19. Reproducing abnormal cholesterol biosynthesis as seen in the Smith-Lemli-Opitz syndrome by inhibiting the conversion of 7-dehydrocholesterol to cholesterol in rats.
Xu G; Salen G; Shefer S; Ness GC; Chen TS; Zhao Z; Tint GS
J Clin Invest; 1995 Jan; 95(1):76-81. PubMed ID: 7814648
[TBL] [Abstract][Full Text] [Related]
20. Abnormal cholesterol biosynthesis in the Smith-Lemli-Opitz syndrome.
Salen G; Tint GS; Xu G; Batta AK; Irons M; Elias ER
Ital J Gastroenterol; 1995 Dec; 27(9):506-8. PubMed ID: 8919321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
